MUC5B and interstitial lung disease: Despite the recent advance with potential diagnostic biomarkers such as the MUC5B promotor variant (6) or sound analysis of vesicular murmur (7), there is a scarcity of factors capable of predicting RA-ILD long-term clinical outcomes.